Drug Shortage Report for RAPAMUNE
Report ID | 149855 |
Drug Identification Number | 02243237 |
Brand name | RAPAMUNE |
Common or Proper name | RAPAMUNE |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SIROLIMUS |
Strength(s) | 1.0MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | 60ML |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-24 |
Estimated end date | |
Actual end date | 2022-01-04 |
Shortage status | Resolved |
Updated date | 2022-01-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-01-05 | English | Compare |
v5 | 2022-01-04 | French | Compare |
v4 | 2022-01-04 | English | Compare |
v3 | 2021-11-25 | English | Compare |
v2 | 2021-11-24 | French | Compare |
v1 | 2021-11-24 | English | Compare |
Showing 1 to 6 of 6